Clinical significance ofin vivocytarabine-induced gene expression signature in AML
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical significance ofin vivocytarabine-induced gene expression signature in AML
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 57, Issue 4, Pages 909-920
Publisher
Informa UK Limited
Online
2015-10-16
DOI
10.3109/10428194.2015.1086918
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia
- (2015) H Wu et al. LEUKEMIA
- Strong induction of iodothyronine deiodinases by chemotherapeutic selenocompounds
- (2015) M. Stoedter et al. Metallomics
- Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia
- (2014) A. Agarwal et al. CLINICAL CANCER RESEARCH
- Tif1 regulates the TGF- 1 receptor and promotes physiological aging of hematopoietic stem cells
- (2014) R. Quere et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polybromo-1 (PBRM1), a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma
- (2013) Walter H. da Costa et al. BJU INTERNATIONAL
- Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia
- (2013) S. A. Rushworth et al. BLOOD
- Tripartite Motif-containing 33 (TRIM33) Protein Functions in the Poly(ADP-ribose) Polymerase (PARP)-dependent DNA Damage Response through Interaction with Amplified in Liver Cancer 1 (ALC1) Protein
- (2013) Atul Kulkarni et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic Variation in the Extended Major Histocompatibility Complex and Susceptibility to Childhood Acute Lymphoblastic Leukemia: A Review of the Evidence
- (2013) Kevin Y. Urayama et al. Frontiers in Oncology
- Cancer and the bromodomains of BAF180
- (2012) Peter M. Brownlee et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Loss of PBRM1 expression is associated with renal cell carcinoma progression
- (2012) Rafal Pawłowski et al. INTERNATIONAL JOURNAL OF CANCER
- Risk of developing chronic lymphocytic leukemia is influenced by HLA-A class I variation
- (2012) M C Di Bernardo et al. LEUKEMIA
- A role for chromatin remodellers in replication of damaged DNA
- (2012) A. Niimi et al. NUCLEIC ACIDS RESEARCH
- Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes
- (2011) Jatinder K Lamba et al. PHARMACOGENOMICS
- Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
- (2010) Jeffrey E Rubnitz et al. LANCET ONCOLOGY
- Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence
- (2010) A. E. Burrows et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PROMISE: a tool to identify genomic features with a specific biologically interesting pattern of associations with multiple endpoint variables
- (2009) Stan Pounds et al. BIOINFORMATICS
- Polybromo-1: The chromatin targeting subunit of the PBAF complex
- (2008) Martin Thompson BIOCHIMIE
- Acute Myeloid Leukemia
- (2008) Jeffrey E. Rubnitz et al. PEDIATRIC CLINICS OF NORTH AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started